nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—ABCC2—Carboplatin—uterine cancer	0.224	0.415	CbGbCtD
Olmesartan—ABCC2—Etoposide—uterine cancer	0.188	0.348	CbGbCtD
Olmesartan—ABCC2—Doxorubicin—uterine cancer	0.129	0.237	CbGbCtD
Olmesartan—AGTR1—artery—uterine cancer	0.0106	0.178	CbGeAlD
Olmesartan—AGTR1—myometrium—uterine cancer	0.0051	0.086	CbGeAlD
Olmesartan—SLCO1B3—vagina—uterine cancer	0.00443	0.0748	CbGeAlD
Olmesartan—AGTR1—epithelium—uterine cancer	0.004	0.0675	CbGeAlD
Olmesartan—AGTR1—uterine cervix—uterine cancer	0.00397	0.0669	CbGeAlD
Olmesartan—AGTR1—smooth muscle tissue—uterine cancer	0.00386	0.0651	CbGeAlD
Olmesartan—AGTR1—decidua—uterine cancer	0.00378	0.0638	CbGeAlD
Olmesartan—AGTR1—renal system—uterine cancer	0.00371	0.0626	CbGeAlD
Olmesartan—SLCO1B1—renal system—uterine cancer	0.00354	0.0597	CbGeAlD
Olmesartan—AGTR1—female reproductive system—uterine cancer	0.00297	0.0502	CbGeAlD
Olmesartan—SLCO1B1—female reproductive system—uterine cancer	0.00283	0.0478	CbGeAlD
Olmesartan—AGTR1—vagina—uterine cancer	0.00269	0.0454	CbGeAlD
Olmesartan—ABCC2—renal system—uterine cancer	0.00268	0.0453	CbGeAlD
Olmesartan—ABCC2—female reproductive system—uterine cancer	0.00215	0.0363	CbGeAlD
Olmesartan—AGTR1—lymph node—uterine cancer	0.00174	0.0293	CbGeAlD
Olmesartan—ABCC2—lymph node—uterine cancer	0.00126	0.0212	CbGeAlD
Olmesartan—Diabetes mellitus—Doxorubicin—uterine cancer	0.000634	0.00159	CcSEcCtD
Olmesartan—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000633	0.00159	CcSEcCtD
Olmesartan—Decreased appetite—Dactinomycin—uterine cancer	0.000627	0.00157	CcSEcCtD
Olmesartan—Fatigue—Dactinomycin—uterine cancer	0.000622	0.00156	CcSEcCtD
Olmesartan—Back pain—Etoposide—uterine cancer	0.000619	0.00155	CcSEcCtD
Olmesartan—Pain—Dactinomycin—uterine cancer	0.000617	0.00155	CcSEcCtD
Olmesartan—Muscle spasms—Etoposide—uterine cancer	0.000615	0.00154	CcSEcCtD
Olmesartan—Eczema—Doxorubicin—uterine cancer	0.000613	0.00154	CcSEcCtD
Olmesartan—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000612	0.00153	CcSEcCtD
Olmesartan—Lethargy—Epirubicin—uterine cancer	0.000608	0.00152	CcSEcCtD
Olmesartan—Nausea—Progesterone—uterine cancer	0.000607	0.00152	CcSEcCtD
Olmesartan—Hyponatraemia—Epirubicin—uterine cancer	0.000598	0.0015	CcSEcCtD
Olmesartan—Renal failure acute—Doxorubicin—uterine cancer	0.000597	0.0015	CcSEcCtD
Olmesartan—Pain in extremity—Epirubicin—uterine cancer	0.000596	0.00149	CcSEcCtD
Olmesartan—Feeling abnormal—Dactinomycin—uterine cancer	0.000595	0.00149	CcSEcCtD
Olmesartan—Ill-defined disorder—Etoposide—uterine cancer	0.000594	0.00149	CcSEcCtD
Olmesartan—Anaemia—Etoposide—uterine cancer	0.000592	0.00148	CcSEcCtD
Olmesartan—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00059	0.00148	CcSEcCtD
Olmesartan—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000588	0.00147	CcSEcCtD
Olmesartan—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000583	0.00146	CcSEcCtD
Olmesartan—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000583	0.00146	CcSEcCtD
Olmesartan—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00058	0.00145	CcSEcCtD
Olmesartan—Malaise—Etoposide—uterine cancer	0.000577	0.00145	CcSEcCtD
Olmesartan—Face oedema—Epirubicin—uterine cancer	0.000575	0.00144	CcSEcCtD
Olmesartan—Vertigo—Etoposide—uterine cancer	0.000575	0.00144	CcSEcCtD
Olmesartan—Leukopenia—Etoposide—uterine cancer	0.000573	0.00143	CcSEcCtD
Olmesartan—Abdominal pain—Dactinomycin—uterine cancer	0.000571	0.00143	CcSEcCtD
Olmesartan—Body temperature increased—Dactinomycin—uterine cancer	0.000571	0.00143	CcSEcCtD
Olmesartan—Loss of consciousness—Etoposide—uterine cancer	0.000563	0.00141	CcSEcCtD
Olmesartan—Lethargy—Doxorubicin—uterine cancer	0.000563	0.00141	CcSEcCtD
Olmesartan—Cough—Etoposide—uterine cancer	0.000559	0.0014	CcSEcCtD
Olmesartan—Blood creatinine increased—Epirubicin—uterine cancer	0.000558	0.0014	CcSEcCtD
Olmesartan—Hyponatraemia—Doxorubicin—uterine cancer	0.000553	0.00139	CcSEcCtD
Olmesartan—Pain in extremity—Doxorubicin—uterine cancer	0.000551	0.00138	CcSEcCtD
Olmesartan—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00055	0.00138	CcSEcCtD
Olmesartan—Chest pain—Etoposide—uterine cancer	0.000545	0.00136	CcSEcCtD
Olmesartan—Orthostatic hypotension—Epirubicin—uterine cancer	0.000544	0.00136	CcSEcCtD
Olmesartan—Hypokalaemia—Epirubicin—uterine cancer	0.000542	0.00136	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000541	0.00136	CcSEcCtD
Olmesartan—Discomfort—Etoposide—uterine cancer	0.000538	0.00135	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000536	0.00134	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000536	0.00134	CcSEcCtD
Olmesartan—Nasopharyngitis—Epirubicin—uterine cancer	0.000533	0.00133	CcSEcCtD
Olmesartan—Face oedema—Doxorubicin—uterine cancer	0.000532	0.00133	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000525	0.00132	CcSEcCtD
Olmesartan—Anaphylactic shock—Etoposide—uterine cancer	0.000522	0.00131	CcSEcCtD
Olmesartan—Infection—Etoposide—uterine cancer	0.000519	0.0013	CcSEcCtD
Olmesartan—Asthenia—Dactinomycin—uterine cancer	0.000518	0.0013	CcSEcCtD
Olmesartan—Blood creatinine increased—Doxorubicin—uterine cancer	0.000516	0.00129	CcSEcCtD
Olmesartan—Influenza—Epirubicin—uterine cancer	0.000515	0.00129	CcSEcCtD
Olmesartan—Thrombocytopenia—Etoposide—uterine cancer	0.000511	0.00128	CcSEcCtD
Olmesartan—Tachycardia—Etoposide—uterine cancer	0.00051	0.00128	CcSEcCtD
Olmesartan—Eosinophilia—Epirubicin—uterine cancer	0.00051	0.00128	CcSEcCtD
Olmesartan—Skin disorder—Etoposide—uterine cancer	0.000507	0.00127	CcSEcCtD
Olmesartan—Hyperhidrosis—Etoposide—uterine cancer	0.000505	0.00126	CcSEcCtD
Olmesartan—Pancreatitis—Epirubicin—uterine cancer	0.000505	0.00126	CcSEcCtD
Olmesartan—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000503	0.00126	CcSEcCtD
Olmesartan—Hypokalaemia—Doxorubicin—uterine cancer	0.000502	0.00126	CcSEcCtD
Olmesartan—Angina pectoris—Epirubicin—uterine cancer	0.000502	0.00126	CcSEcCtD
Olmesartan—Anorexia—Etoposide—uterine cancer	0.000498	0.00125	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000496	0.00124	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000496	0.00124	CcSEcCtD
Olmesartan—Bronchitis—Epirubicin—uterine cancer	0.000495	0.00124	CcSEcCtD
Olmesartan—Diarrhoea—Dactinomycin—uterine cancer	0.000494	0.00124	CcSEcCtD
Olmesartan—Nasopharyngitis—Doxorubicin—uterine cancer	0.000493	0.00123	CcSEcCtD
Olmesartan—Pancytopenia—Epirubicin—uterine cancer	0.000489	0.00122	CcSEcCtD
Olmesartan—Hypotension—Etoposide—uterine cancer	0.000488	0.00122	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000486	0.00122	CcSEcCtD
Olmesartan—Neutropenia—Epirubicin—uterine cancer	0.000481	0.00121	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000479	0.0012	CcSEcCtD
Olmesartan—Influenza—Doxorubicin—uterine cancer	0.000476	0.00119	CcSEcCtD
Olmesartan—Eosinophilia—Doxorubicin—uterine cancer	0.000472	0.00118	CcSEcCtD
Olmesartan—Photosensitivity reaction—Epirubicin—uterine cancer	0.00047	0.00118	CcSEcCtD
Olmesartan—Pancreatitis—Doxorubicin—uterine cancer	0.000467	0.00117	CcSEcCtD
Olmesartan—Hyperglycaemia—Epirubicin—uterine cancer	0.000464	0.00116	CcSEcCtD
Olmesartan—Angina pectoris—Doxorubicin—uterine cancer	0.000464	0.00116	CcSEcCtD
Olmesartan—Pneumonia—Epirubicin—uterine cancer	0.000462	0.00116	CcSEcCtD
Olmesartan—Infestation NOS—Epirubicin—uterine cancer	0.000459	0.00115	CcSEcCtD
Olmesartan—Infestation—Epirubicin—uterine cancer	0.000459	0.00115	CcSEcCtD
Olmesartan—Vomiting—Dactinomycin—uterine cancer	0.000459	0.00115	CcSEcCtD
Olmesartan—Bronchitis—Doxorubicin—uterine cancer	0.000458	0.00115	CcSEcCtD
Olmesartan—Rash—Dactinomycin—uterine cancer	0.000455	0.00114	CcSEcCtD
Olmesartan—Decreased appetite—Etoposide—uterine cancer	0.000454	0.00114	CcSEcCtD
Olmesartan—Pancytopenia—Doxorubicin—uterine cancer	0.000452	0.00113	CcSEcCtD
Olmesartan—Renal failure—Epirubicin—uterine cancer	0.000451	0.00113	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Etoposide—uterine cancer	0.000451	0.00113	CcSEcCtD
Olmesartan—Fatigue—Etoposide—uterine cancer	0.00045	0.00113	CcSEcCtD
Olmesartan—Jaundice—Epirubicin—uterine cancer	0.000448	0.00112	CcSEcCtD
Olmesartan—Constipation—Etoposide—uterine cancer	0.000447	0.00112	CcSEcCtD
Olmesartan—Pain—Etoposide—uterine cancer	0.000447	0.00112	CcSEcCtD
Olmesartan—Urinary tract infection—Epirubicin—uterine cancer	0.000446	0.00112	CcSEcCtD
Olmesartan—Neutropenia—Doxorubicin—uterine cancer	0.000446	0.00112	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000443	0.00111	CcSEcCtD
Olmesartan—Haematuria—Epirubicin—uterine cancer	0.000438	0.0011	CcSEcCtD
Olmesartan—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000435	0.00109	CcSEcCtD
Olmesartan—Sinusitis—Epirubicin—uterine cancer	0.000431	0.00108	CcSEcCtD
Olmesartan—Feeling abnormal—Etoposide—uterine cancer	0.00043	0.00108	CcSEcCtD
Olmesartan—Hyperglycaemia—Doxorubicin—uterine cancer	0.00043	0.00108	CcSEcCtD
Olmesartan—Nausea—Dactinomycin—uterine cancer	0.000429	0.00107	CcSEcCtD
Olmesartan—Agranulocytosis—Epirubicin—uterine cancer	0.000428	0.00107	CcSEcCtD
Olmesartan—Pneumonia—Doxorubicin—uterine cancer	0.000427	0.00107	CcSEcCtD
Olmesartan—Gastrointestinal pain—Etoposide—uterine cancer	0.000427	0.00107	CcSEcCtD
Olmesartan—Infestation NOS—Doxorubicin—uterine cancer	0.000425	0.00106	CcSEcCtD
Olmesartan—Infestation—Doxorubicin—uterine cancer	0.000425	0.00106	CcSEcCtD
Olmesartan—Renal failure—Doxorubicin—uterine cancer	0.000418	0.00105	CcSEcCtD
Olmesartan—Urticaria—Etoposide—uterine cancer	0.000415	0.00104	CcSEcCtD
Olmesartan—Jaundice—Doxorubicin—uterine cancer	0.000414	0.00104	CcSEcCtD
Olmesartan—Rhinitis—Epirubicin—uterine cancer	0.000413	0.00103	CcSEcCtD
Olmesartan—Abdominal pain—Etoposide—uterine cancer	0.000413	0.00103	CcSEcCtD
Olmesartan—Body temperature increased—Etoposide—uterine cancer	0.000413	0.00103	CcSEcCtD
Olmesartan—Urinary tract infection—Doxorubicin—uterine cancer	0.000413	0.00103	CcSEcCtD
Olmesartan—Pharyngitis—Epirubicin—uterine cancer	0.000409	0.00102	CcSEcCtD
Olmesartan—Urinary tract disorder—Epirubicin—uterine cancer	0.000407	0.00102	CcSEcCtD
Olmesartan—Oedema peripheral—Epirubicin—uterine cancer	0.000406	0.00102	CcSEcCtD
Olmesartan—Haematuria—Doxorubicin—uterine cancer	0.000405	0.00101	CcSEcCtD
Olmesartan—Connective tissue disorder—Epirubicin—uterine cancer	0.000405	0.00101	CcSEcCtD
Olmesartan—Urethral disorder—Epirubicin—uterine cancer	0.000404	0.00101	CcSEcCtD
Olmesartan—Sinusitis—Doxorubicin—uterine cancer	0.000399	0.000998	CcSEcCtD
Olmesartan—Agranulocytosis—Doxorubicin—uterine cancer	0.000396	0.000993	CcSEcCtD
Olmesartan—Rhinitis—Doxorubicin—uterine cancer	0.000382	0.000958	CcSEcCtD
Olmesartan—Pharyngitis—Doxorubicin—uterine cancer	0.000378	0.000948	CcSEcCtD
Olmesartan—Urinary tract disorder—Doxorubicin—uterine cancer	0.000377	0.000943	CcSEcCtD
Olmesartan—Oedema peripheral—Doxorubicin—uterine cancer	0.000376	0.000941	CcSEcCtD
Olmesartan—Asthenia—Etoposide—uterine cancer	0.000375	0.000939	CcSEcCtD
Olmesartan—Connective tissue disorder—Doxorubicin—uterine cancer	0.000375	0.000939	CcSEcCtD
Olmesartan—Angiopathy—Epirubicin—uterine cancer	0.000374	0.000937	CcSEcCtD
Olmesartan—Urethral disorder—Doxorubicin—uterine cancer	0.000374	0.000936	CcSEcCtD
Olmesartan—Mediastinal disorder—Epirubicin—uterine cancer	0.000371	0.00093	CcSEcCtD
Olmesartan—Pruritus—Etoposide—uterine cancer	0.00037	0.000926	CcSEcCtD
Olmesartan—Arrhythmia—Epirubicin—uterine cancer	0.000368	0.000922	CcSEcCtD
Olmesartan—Alopecia—Epirubicin—uterine cancer	0.000364	0.000912	CcSEcCtD
Olmesartan—Mental disorder—Epirubicin—uterine cancer	0.000361	0.000904	CcSEcCtD
Olmesartan—Malnutrition—Epirubicin—uterine cancer	0.000359	0.000899	CcSEcCtD
Olmesartan—Diarrhoea—Etoposide—uterine cancer	0.000357	0.000895	CcSEcCtD
Olmesartan—Back pain—Epirubicin—uterine cancer	0.000347	0.000869	CcSEcCtD
Olmesartan—Angiopathy—Doxorubicin—uterine cancer	0.000346	0.000867	CcSEcCtD
Olmesartan—Dizziness—Etoposide—uterine cancer	0.000345	0.000865	CcSEcCtD
Olmesartan—Muscle spasms—Epirubicin—uterine cancer	0.000345	0.000864	CcSEcCtD
Olmesartan—Mediastinal disorder—Doxorubicin—uterine cancer	0.000344	0.000861	CcSEcCtD
Olmesartan—Arrhythmia—Doxorubicin—uterine cancer	0.000341	0.000853	CcSEcCtD
Olmesartan—Vision blurred—Epirubicin—uterine cancer	0.000338	0.000847	CcSEcCtD
Olmesartan—Alopecia—Doxorubicin—uterine cancer	0.000337	0.000844	CcSEcCtD
Olmesartan—Mental disorder—Doxorubicin—uterine cancer	0.000334	0.000837	CcSEcCtD
Olmesartan—Ill-defined disorder—Epirubicin—uterine cancer	0.000333	0.000834	CcSEcCtD
Olmesartan—Vomiting—Etoposide—uterine cancer	0.000332	0.000832	CcSEcCtD
Olmesartan—Malnutrition—Doxorubicin—uterine cancer	0.000332	0.000831	CcSEcCtD
Olmesartan—Anaemia—Epirubicin—uterine cancer	0.000332	0.000831	CcSEcCtD
Olmesartan—Agitation—Epirubicin—uterine cancer	0.00033	0.000826	CcSEcCtD
Olmesartan—Rash—Etoposide—uterine cancer	0.000329	0.000825	CcSEcCtD
Olmesartan—Dermatitis—Etoposide—uterine cancer	0.000329	0.000824	CcSEcCtD
Olmesartan—Headache—Etoposide—uterine cancer	0.000327	0.00082	CcSEcCtD
Olmesartan—Malaise—Epirubicin—uterine cancer	0.000324	0.00081	CcSEcCtD
Olmesartan—Vertigo—Epirubicin—uterine cancer	0.000322	0.000807	CcSEcCtD
Olmesartan—Syncope—Epirubicin—uterine cancer	0.000322	0.000806	CcSEcCtD
Olmesartan—Leukopenia—Epirubicin—uterine cancer	0.000321	0.000804	CcSEcCtD
Olmesartan—Back pain—Doxorubicin—uterine cancer	0.000321	0.000804	CcSEcCtD
Olmesartan—Muscle spasms—Doxorubicin—uterine cancer	0.000319	0.000799	CcSEcCtD
Olmesartan—Palpitations—Epirubicin—uterine cancer	0.000317	0.000794	CcSEcCtD
Olmesartan—Loss of consciousness—Epirubicin—uterine cancer	0.000315	0.00079	CcSEcCtD
Olmesartan—Cough—Epirubicin—uterine cancer	0.000313	0.000784	CcSEcCtD
Olmesartan—Vision blurred—Doxorubicin—uterine cancer	0.000313	0.000784	CcSEcCtD
Olmesartan—Nausea—Etoposide—uterine cancer	0.00031	0.000777	CcSEcCtD
Olmesartan—Ill-defined disorder—Doxorubicin—uterine cancer	0.000308	0.000771	CcSEcCtD
Olmesartan—Anaemia—Doxorubicin—uterine cancer	0.000307	0.000768	CcSEcCtD
Olmesartan—Arthralgia—Epirubicin—uterine cancer	0.000305	0.000765	CcSEcCtD
Olmesartan—Myalgia—Epirubicin—uterine cancer	0.000305	0.000765	CcSEcCtD
Olmesartan—Chest pain—Epirubicin—uterine cancer	0.000305	0.000765	CcSEcCtD
Olmesartan—Agitation—Doxorubicin—uterine cancer	0.000305	0.000764	CcSEcCtD
Olmesartan—Anxiety—Epirubicin—uterine cancer	0.000304	0.000762	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000303	0.00076	CcSEcCtD
Olmesartan—Discomfort—Epirubicin—uterine cancer	0.000302	0.000756	CcSEcCtD
Olmesartan—Malaise—Doxorubicin—uterine cancer	0.000299	0.00075	CcSEcCtD
Olmesartan—Vertigo—Doxorubicin—uterine cancer	0.000298	0.000747	CcSEcCtD
Olmesartan—Syncope—Doxorubicin—uterine cancer	0.000298	0.000746	CcSEcCtD
Olmesartan—Leukopenia—Doxorubicin—uterine cancer	0.000297	0.000744	CcSEcCtD
Olmesartan—Palpitations—Doxorubicin—uterine cancer	0.000293	0.000735	CcSEcCtD
Olmesartan—Anaphylactic shock—Epirubicin—uterine cancer	0.000293	0.000733	CcSEcCtD
Olmesartan—Oedema—Epirubicin—uterine cancer	0.000293	0.000733	CcSEcCtD
Olmesartan—Loss of consciousness—Doxorubicin—uterine cancer	0.000292	0.000731	CcSEcCtD
Olmesartan—Infection—Epirubicin—uterine cancer	0.000291	0.000729	CcSEcCtD
Olmesartan—Cough—Doxorubicin—uterine cancer	0.00029	0.000726	CcSEcCtD
Olmesartan—Shock—Epirubicin—uterine cancer	0.000288	0.000722	CcSEcCtD
Olmesartan—Nervous system disorder—Epirubicin—uterine cancer	0.000287	0.000719	CcSEcCtD
Olmesartan—Thrombocytopenia—Epirubicin—uterine cancer	0.000287	0.000718	CcSEcCtD
Olmesartan—Tachycardia—Epirubicin—uterine cancer	0.000286	0.000716	CcSEcCtD
Olmesartan—Skin disorder—Epirubicin—uterine cancer	0.000284	0.000712	CcSEcCtD
Olmesartan—Hyperhidrosis—Epirubicin—uterine cancer	0.000283	0.000709	CcSEcCtD
Olmesartan—Arthralgia—Doxorubicin—uterine cancer	0.000283	0.000708	CcSEcCtD
Olmesartan—Myalgia—Doxorubicin—uterine cancer	0.000283	0.000708	CcSEcCtD
Olmesartan—Chest pain—Doxorubicin—uterine cancer	0.000283	0.000708	CcSEcCtD
Olmesartan—Anxiety—Doxorubicin—uterine cancer	0.000282	0.000705	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000281	0.000703	CcSEcCtD
Olmesartan—Discomfort—Doxorubicin—uterine cancer	0.000279	0.000699	CcSEcCtD
Olmesartan—Anorexia—Epirubicin—uterine cancer	0.000279	0.000699	CcSEcCtD
Olmesartan—Hypotension—Epirubicin—uterine cancer	0.000274	0.000685	CcSEcCtD
Olmesartan—Anaphylactic shock—Doxorubicin—uterine cancer	0.000271	0.000679	CcSEcCtD
Olmesartan—Oedema—Doxorubicin—uterine cancer	0.000271	0.000679	CcSEcCtD
Olmesartan—Infection—Doxorubicin—uterine cancer	0.000269	0.000674	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000267	0.000668	CcSEcCtD
Olmesartan—Shock—Doxorubicin—uterine cancer	0.000267	0.000668	CcSEcCtD
Olmesartan—Nervous system disorder—Doxorubicin—uterine cancer	0.000266	0.000665	CcSEcCtD
Olmesartan—Thrombocytopenia—Doxorubicin—uterine cancer	0.000265	0.000664	CcSEcCtD
Olmesartan—Insomnia—Epirubicin—uterine cancer	0.000265	0.000663	CcSEcCtD
Olmesartan—Tachycardia—Doxorubicin—uterine cancer	0.000264	0.000662	CcSEcCtD
Olmesartan—Skin disorder—Doxorubicin—uterine cancer	0.000263	0.000659	CcSEcCtD
Olmesartan—Hyperhidrosis—Doxorubicin—uterine cancer	0.000262	0.000656	CcSEcCtD
Olmesartan—Anorexia—Doxorubicin—uterine cancer	0.000258	0.000647	CcSEcCtD
Olmesartan—Dyspepsia—Epirubicin—uterine cancer	0.000258	0.000646	CcSEcCtD
Olmesartan—Decreased appetite—Epirubicin—uterine cancer	0.000255	0.000638	CcSEcCtD
Olmesartan—Hypotension—Doxorubicin—uterine cancer	0.000253	0.000634	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000253	0.000633	CcSEcCtD
Olmesartan—Fatigue—Epirubicin—uterine cancer	0.000252	0.000632	CcSEcCtD
Olmesartan—Pain—Epirubicin—uterine cancer	0.00025	0.000627	CcSEcCtD
Olmesartan—Constipation—Epirubicin—uterine cancer	0.00025	0.000627	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000247	0.000618	CcSEcCtD
Olmesartan—Insomnia—Doxorubicin—uterine cancer	0.000245	0.000614	CcSEcCtD
Olmesartan—Feeling abnormal—Epirubicin—uterine cancer	0.000241	0.000604	CcSEcCtD
Olmesartan—Gastrointestinal pain—Epirubicin—uterine cancer	0.000239	0.0006	CcSEcCtD
Olmesartan—Dyspepsia—Doxorubicin—uterine cancer	0.000238	0.000597	CcSEcCtD
Olmesartan—Decreased appetite—Doxorubicin—uterine cancer	0.000236	0.00059	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000234	0.000586	CcSEcCtD
Olmesartan—Fatigue—Doxorubicin—uterine cancer	0.000234	0.000585	CcSEcCtD
Olmesartan—Urticaria—Epirubicin—uterine cancer	0.000233	0.000583	CcSEcCtD
Olmesartan—Pain—Doxorubicin—uterine cancer	0.000232	0.00058	CcSEcCtD
Olmesartan—Constipation—Doxorubicin—uterine cancer	0.000232	0.00058	CcSEcCtD
Olmesartan—Abdominal pain—Epirubicin—uterine cancer	0.000231	0.00058	CcSEcCtD
Olmesartan—Body temperature increased—Epirubicin—uterine cancer	0.000231	0.00058	CcSEcCtD
Olmesartan—Feeling abnormal—Doxorubicin—uterine cancer	0.000223	0.000559	CcSEcCtD
Olmesartan—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000222	0.000555	CcSEcCtD
Olmesartan—Urticaria—Doxorubicin—uterine cancer	0.000215	0.000539	CcSEcCtD
Olmesartan—Abdominal pain—Doxorubicin—uterine cancer	0.000214	0.000536	CcSEcCtD
Olmesartan—Body temperature increased—Doxorubicin—uterine cancer	0.000214	0.000536	CcSEcCtD
Olmesartan—Asthenia—Epirubicin—uterine cancer	0.00021	0.000526	CcSEcCtD
Olmesartan—Pruritus—Epirubicin—uterine cancer	0.000207	0.000519	CcSEcCtD
Olmesartan—Diarrhoea—Epirubicin—uterine cancer	0.0002	0.000502	CcSEcCtD
Olmesartan—Asthenia—Doxorubicin—uterine cancer	0.000194	0.000487	CcSEcCtD
Olmesartan—Dizziness—Epirubicin—uterine cancer	0.000194	0.000485	CcSEcCtD
Olmesartan—Pruritus—Doxorubicin—uterine cancer	0.000192	0.00048	CcSEcCtD
Olmesartan—Vomiting—Epirubicin—uterine cancer	0.000186	0.000466	CcSEcCtD
Olmesartan—Diarrhoea—Doxorubicin—uterine cancer	0.000185	0.000464	CcSEcCtD
Olmesartan—Rash—Epirubicin—uterine cancer	0.000185	0.000462	CcSEcCtD
Olmesartan—Dermatitis—Epirubicin—uterine cancer	0.000184	0.000462	CcSEcCtD
Olmesartan—Headache—Epirubicin—uterine cancer	0.000183	0.000459	CcSEcCtD
Olmesartan—Dizziness—Doxorubicin—uterine cancer	0.000179	0.000449	CcSEcCtD
Olmesartan—Nausea—Epirubicin—uterine cancer	0.000174	0.000436	CcSEcCtD
Olmesartan—Vomiting—Doxorubicin—uterine cancer	0.000172	0.000431	CcSEcCtD
Olmesartan—Rash—Doxorubicin—uterine cancer	0.000171	0.000428	CcSEcCtD
Olmesartan—Dermatitis—Doxorubicin—uterine cancer	0.000171	0.000427	CcSEcCtD
Olmesartan—Headache—Doxorubicin—uterine cancer	0.00017	0.000425	CcSEcCtD
Olmesartan—Nausea—Doxorubicin—uterine cancer	0.000161	0.000403	CcSEcCtD
